Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers Aged 18-36 months: A phase 1 randomized-controlled clinical trial

H.S. Marshall, Peter Richmond, M.D. Nissen, Q. Jiang, A.S. Anderson, K.U. Jansen, G. Reynolds, J.B. Ziegler, S.L. Harris, T.R. Jones, J.L. Perez

    Research output: Contribution to journalArticle

    55 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1061-1068
    JournalPediatric Infectious Disease Journal
    Issue number10
    Publication statusPublished - 2012

    Cite this